Search

Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals is a Melbourne-based company that listed on the ASX in August 2015. Paradigm is developing potential orthopaedic and respiratory applications of pentosan polysulphate sodium.
Bio last updated 16 Jan 2017

Latest Equity Capital Markets Deals

DateCompanyTransaction TypeTotal Value
18/10/16Paradigm Biopharmaceuticals$6.2m>>

BNiQ Disclaimer